CLLS Stock Analysis: Buy, Sell, or Hold?
CLLS - Cellectis S.A. American Depositary Shares
$3.29
-0.01 (-0.30%)
▼
5d:
+16.25%
30d:
+6.47%
90d:
-3.52%
BUY
HIGH Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 03, 2026
27d
Get Alerted When CLLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CLLS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: CLLS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: CLLS is currently trading at $3.29, which is considered slightly high relative to its 30-day fair value range of $2.88 to $3.31.
Technical Outlook: Technically, CLLS is in a downtrend. The price is approaching resistance at $3.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CLLS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.60 (+131.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CLLS is in a downtrend. The price is approaching resistance at $3.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CLLS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.60 (+131.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.88 -
$3.31
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 131.0% below Wall St target ($7.60)
Trading Range Analysis
30-Day Trading Range
$2.88 -
$3.31
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.70
Resistance Level
$3.19
Current Trend
Downtrend
Technical data as of
Jul 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.72
Wall Street Target
$7.60
(+131.0%)
Revenue Growth (YoY)
-37.3%
Profit Margin
-89.5%
Share & Embed Analysis
Last updated: July 06, 2026 6:09 PM ET
Data refreshes hourly during market hours. Next update: 7:09 PM
Data refreshes hourly during market hours. Next update: 7:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$435 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 56 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 56 HOLD |
